Protocol Summaries: GSK159802
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| B2F104300 | Phase 1 | A randomised, double-blind, placebo controlled study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled dry powder doses of GSK159802 in healthy male subjects and asthmatics | Completed |